{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:23:17Z","timestamp":1790688197352,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytopathology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1111\/cyt.12316","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T15:36:46Z","timestamp":1455377806000},"page":"261-268","source":"Crossref","is-referenced-by-count":13,"title":["HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN"],"prefix":"10.1111","volume":"27","author":[{"given":"M.","family":"McKenna","sequence":"first","affiliation":[{"name":"Cytopathology Department; Altnagelvin Hospital; Londonderry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"McMenamin","sequence":"additional","affiliation":[{"name":"Cytopathology Department; Altnagelvin Hospital; Londonderry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"McDowell","sequence":"additional","affiliation":[{"name":"Northern Ireland Centre for Stratified Medicine; Ulster University; Londonderry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,13]]},"reference":[{"key":"10.1111\/cyt.12316-BIB0001|cyt12316-cit-0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1111\/cyt.12316-BIB0002|cyt12316-cit-0002","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1111\/cyt.12316-BIB0003|cyt12316-cit-0003","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"De Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1111\/cyt.12316-BIB0004|cyt12316-cit-0004","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of woman who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/cyt.12316-BIB0005|cyt12316-cit-0005","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/cyt.12316-BIB0006|cyt12316-cit-0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised control trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1111\/cyt.12316-BIB0007|cyt12316-cit-0007","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1111\/cyt.12316-BIB0008|cyt12316-cit-0008","volume-title":"Achievable Standards, Benchmarks for Reporting, and Criteria for Evaluating Cervical Cytopathology","author":"NHS Cancer Screening Programmes","year":"2012","edition":"3"},{"key":"10.1111\/cyt.12316-BIB0009|cyt12316-cit-0009","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/cyt.12316-BIB0010|cyt12316-cit-0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13510","article-title":"ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1111\/cyt.12316-BIB0011|cyt12316-cit-0011","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cncy.21444","article-title":"Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening programme","volume":"122","author":"McKenna","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1111\/cyt.12316-BIB0012|cyt12316-cit-0012","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/cyt.12316-BIB0013|cyt12316-cit-0013","first-page":"1","volume-title":"NHS Cancer Screening Programmes","author":"NHSCSP","year":"2010"},{"key":"10.1111\/cyt.12316-BIB0014|cyt12316-cit-0014","first-page":"1","volume-title":"NHS Cancer Screening Programmes","author":"NHSCSP","year":"2011"},{"key":"10.1111\/cyt.12316-BIB0015|cyt12316-cit-0015","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"The American Statistician"},{"key":"10.1111\/cyt.12316-BIB0016|cyt12316-cit-0016","volume-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"10.1111\/cyt.12316-BIB0017|cyt12316-cit-0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J Pediatr"},{"key":"10.1111\/cyt.12316-BIB0018|cyt12316-cit-0018","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","article-title":"Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population","volume":"57","author":"Cuschieri","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1111\/cyt.12316-BIB0019|cyt12316-cit-0019","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human papillomavirus infection is transient in young women: a population-based cohort study","volume":"171","author":"Evander","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/cyt.12316-BIB0020|cyt12316-cit-0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/AJCPGW1V2BBWMOCX","article-title":"The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology","volume":"137","author":"Stoler","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/cyt.12316-BIB0021|cyt12316-cit-0021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"B J Cancer"},{"key":"10.1111\/cyt.12316-BIB0022|cyt12316-cit-0022","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","article-title":"Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England","volume":"103","author":"Howell-Jones","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1111\/cyt.12316-BIB0023|cyt12316-cit-0023","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/cyt.12316-BIB0024|cyt12316-cit-0024","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study","volume":"325","author":"Kjaer","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/cyt.12316-BIB0025|cyt12316-cit-0025","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"10.1111\/cyt.12316-BIB0026|cyt12316-cit-0026","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.1111\/cyt.12316-BIB0027|cyt12316-cit-0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1111\/cyt.12316-BIB0028|cyt12316-cit-0028","unstructured":"HSC Public Health Agency NI Quality Assurance Reference Centre Cervical Screening Programme HPV Triage and Test of Cure Protocol http:\/\/www.cancerscreening.hscni.net\/2161.htm#leaflets"},{"key":"10.1111\/cyt.12316-BIB0029|cyt12316-cit-0029","unstructured":"Public Health England NHS Cancer Screening Programmes NHS Cervical Screening Programme Screening Protocol Algorithm for HPV Triage and TOC http:\/\/www.cancerscreening.nhs.uk\/cervical\/hpv-triage-test-flowchart-201407.pdf"},{"key":"10.1111\/cyt.12316-BIB0030|cyt12316-cit-0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cyt.12247","article-title":"The impact of HPV triage and test of cure and primary HPV screening on a colposcopy service in England","volume":"26","author":"Palmer","year":"2015","journal-title":"Cytopathology"},{"key":"10.1111\/cyt.12316-BIB0031|cyt12316-cit-0031","unstructured":"NHS Cancer Screening Programmes HPV primary screening algorithm - pilot year 1. 2013 http:\/\/pathlabs.rlbuht.nhs.uk\/hisgynaecytoHPVflowchart.pdf"}],"container-title":["Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcyt.12316","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T05:50:30Z","timestamp":1498283430000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/cyt.12316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,13]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1111\/cyt.12316","archive":["Portico"],"relation":{},"ISSN":["0956-5507"],"issn-type":[{"value":"0956-5507","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2,13]]}}}